CPT1A is the most widely distributed isoform of the CPT1 family, and its aberrant expression can lead to metabolic disorders and the progression of various cancers (Schlaepfer and Joshi, 2020; Liang, 2023). This evidence concerns the gene CPT1A and Other metabolic disease.